Press Releases Poolbeg Pharma PLC

Equities

POLB

GB00BKPG7Z60

Market Closed - London S.E. Other stock markets 09:05:27 17/05/2024 pm IST			5-day change	1st Jan Change
12.8 ^GBX	0.00%		-6.91%	+41.44%

01/05	Poolbeg Pharma Secures Full Patent in US for Immunomodulator II	MT
01/05	Poolbeg Pharma celebrates full patent approval for Immunomodulator II	AN

Press Releases

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Poolbeg Pharma plc - Annual Report and AGM Notice	10/05	AQ
Poolbeg Pharma's POLB 001 immuno-modulator II receives fully-granted patent from US Patent Office	08/05	AQ
Poolbeg Pharma and Silk Road Therapeutics announce strategic collaboration on novel orphan drug	01/05	AQ
Poolbeg Pharma plc - Appointment of Joint Broker	01/05	AQ
Poolbeg Pharma plc - Director Share Purchase	23/02	AQ
Poolbeg Pharma plc - Director Share Purchase	20/02	AQ
Poolbeg Pharma chair discusses shift to executive role; hVIVO share sale	20/02	AQ
Poolbeg Pharma says research confirms $10B plus opportunity for POLB 001 in cancer immunotherapies	12/02	AQ
Poolbeg Pharma's new VP of Clinical Operations Laura Maher aims to help progress development assets	08/02	AQ
Poolbeg Pharma plc - Further Data Confirms POLB 001's Potential in Cancer Immunotherapy-Induced Cytokine Release Syndrome	18/01	AQ
Poolbeg Pharma plc - POLB 001 Data Presented at ASH	12/12	AQ
Poolbeg Pharma plc - Immunomodulator II patent granted in Japan	22/11	AQ
Poolbeg Pharma plc - POLB 001 LPS Challenge Trial Data to be presented at IUIS	17/11	AQ
Poolbeg Pharma "continuing its campaign to find a partner" for POLB001	02/11	AQ
Poolbeg Pharma unveils new collaboration agreement	18/23/18	AQ
Poolbeg Pharma "moving forward rapidly" with POLB001	13/23/13	AQ
Poolbeg Pharma and CytoReason identify "very exciting influenza targets"	29/23/29	AQ
Poolbeg Pharma sees "significant commercial opportunity" in oral vaccines	22/23/22	AQ
Poolbeg Pharma's new NED looking at "new opportunities" for the business	26/23/26	AQ
Poolbeg Pharma "in a very healthy cash position" after first full year of operations	30/23/30	AQ

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Press Releases Poolbeg Pharma PLC

Equities

POLB

GB00BKPG7Z60

Press Releases

Filters